ICG HY26 profit before tax falls 2.9% to EUR 19.9 million; revenue rises 16.1% to EUR 359.9 million
Reuters2026/08/19 12:41- ICG revenue rose 16.1% to €359.9 million in the half-year ended June 30, 2026; operating profit slipped 2.4% to €24 million.
- Profit before tax edged down 2.9% to €19.9 million; basic earnings per share increased 5.9% to 12.5c.
- EBITDA climbed 7.3% to €58.9 million; net debt increased 0.9% to €226.2 million.
- Car volumes fell 5.7% to 249,700; RoRo freight volumes rose 4.1% to 409,500 units.
- Board backed a recommended €8 per share cash offer from Bluefin Bidco; interim dividend for 2026 not proposed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
